Skip to main content

October 2015

 

 

academics

 

Clinical research courses

Work as Pharmacist in NPCIL

NPCIL, a premier Public Sector Enterprise under Department of Atomic Energy, Government of India having comprehensive capability in all facets of Nuclear Technology namely, Site Selection, Design, Construction, Commissioning, Operation, Maintenance, Renovation, Modernization, & Upgradation, Plant life Extension, Waste Management and Decommissioning of Nuclear Reactors in India under one roof, invites applications for its unit “Rawatbhata Rajasthan Site” for the following posts to share these challenging spectrum of responsibilities:

Post: Pharmacist/B

Application are invited for Lecturer in College of Pharmaceutical Sciences, Behrampur

The oldest pharmacy institution in the state of odisha established in 1979, is continuously thriving to produce technical manpower to serve in pharma and different allied sectors. It has become a center of excellence in medicine research having an exclusive ''Cancer Chemotherapeutic Research Unit''

Post: Lecturer

Opening to work as Executive - QA in Piramal Healthcare

Piramal Enterprises Ltd. provides a world class integrated drug discovery services platform from our state-of-the-art research Centre in India. PDS's delivery model has a proven track record of providing a step change in the effectiveness of drug discovery for a range of global pharmaceuticals and biotechnology companies operating at the forefront of drug discovery.

Invites Officer - Quality Control(API) in Mylan

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 16,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.

Post: Officer - Quality Control(API) - 15002950

Opportunity for Executive/Sr.Executive - ARD in Panacea Biotec

Panacea Biotec is a leading research based Health Management Company. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.

We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post: Executive/Sr.Executive - ARD

Requirement for Scientific Positions in Translational Health Science and Technology Institute

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology under the Ministry of Science and Technology, Govt, of India. THSTI is developed as a part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad.

Sun Pharmaceutical Industries Ltd.successfully completed cash tender offered by by Thea Acquisition Corp. (“Thea”), an indirect wholly owned subsidiary of Sun Pharma, for all outstanding shares of common stock of InSite Vision Incorporated (OTCBB: INSV, InSite), which expired at 12:00 midnight, New York City time, (the end of the day) on Tuesday, October 27, 2015.

16% local currency operating profit growth adjusted for the NNIT divestment

Sales increased by 23% in Danish kroner and by 9% in local currencies to DKK 79.1 billion.

  • Sales of Victoza® increased by 39% (21% in local currencies)
  • Sales of Levemir® increased by 27% (10% in local currencies).
  • Sales in North America increased by 33% (10% in local currencies).
  • Sales in International Operations increased by 23% (17% in local currencies).
  • Sales in Region China increased by 26% (5% in local currencies).